Gefitinib Inhibition of Drug Resistance to Doxorubicin by Inactivating ABCG2 in Thyroid Cancer Cell Lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gefitinib Inhibition of Drug Resistance to Doxorubicin by Inactivating ABCG2 in Thyroid Cancer Cell Lines

Published:2007-10-01 Issue:10 Volume:133 Page:1022
ISSN:0886-4470
Container-title:Archives of Otolaryngology–Head & Neck Surgery
language:en
Short-container-title:Arch Otolaryngol Head Neck Surg

Author:

Lopez Jay Patrick,Wang-Rodriguez Jessica,Chang Catherine,Chen Jocelyn S.,Pardo Francisco S.,Aguilera Joseph,Ongkeko Weg M.

Publisher

American Medical Association (AMA)

Subject

General Medicine,Otorhinolaryngology,Surgery

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy;Gastric Cancer;2024-07-20

2. USP10 suppresses ABCG2-induced malignant characteristics of doxorubicin-resistant thyroid cancer by inhibiting PI3K/AKT pathway;Journal of Bioenergetics and Biomembranes;2023-11-03

3. MiR-140 targets Wnt1 to inhibit the proliferation and enhance drug sensitivity in osteosarcoma cells;Cellular and Molecular Biology;2022-05-22

4. The role of ATP-binding cassette transporter genes in the metastatic process of epithelial thyroid carcinoma with aggressive behavior;Unraveling the Complexities of Metastasis;2022

5. Doxorubicin-Resistant TNBC Cells Exhibit Rapid Growth with Cancer Stem Cell-like Properties and EMT Phenotype, Which Can Be Transferred to Parental Cells through Autocrine Signaling;International Journal of Molecular Sciences;2021-11-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP